Solution structure of the general transcription factor 2I domain in mouse TFII-I protein

Protein Science

Volumn 16, Issue 8, 2007, Pages 1788-1792

  Doi Katayama, Yukiko ^a,d   Hayashi, Fumiaki ^a   Inoue, Makoto ^a   Yabuki, Takashi ^a   Aoki, Masaaki ^a   Seki, Eiko ^a   Matsuda, Takayoshi ^a   Kigawa, Takanori ^a   Yoshida, Mayumi ^a   Shirouzu, Mikako ^a   Terada, Takaho ^a   Hayashizaki, Yoshihide ^a   Yokoyama, Shigeyuki ^a,b   Hirota, Hiroshi ^a,c  

^a RIKEN YOKOHAMA INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d NIKON CORPORATION   (Japan)

Author keywords

GTF2I domain; Nuclear magnetic resonance; Protein structure; Transcription factor

Indexed keywords

HELIX LOOP HELIX PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 2I; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; SOLUTIONS; TRANSCRIPTION FACTORS, TFII;

MURINAE;

EID: 34547603552     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1110/ps.072792007     Document Type: Article

References (27)

1. Bax, A. 1994. Multidimensional nuclear magnetic resonance methods for protein studies. Curr. Opin. Struct. Biol. 4: 738-744.
2. Casteel, D.E., Zhuang, S., Gudi, T., Tang, J., Vuica, M., Desiderio, S., and Pilz, R.S. 2002. cGMP-dependent protein kinase Iβ physically and functionally interacts with the transcriptional regulator TFII-I. J. Biol. Chem. 277: 32003-32014.
3. Cavanagh, J., Fairbrother, W.J., Palmer III, A.G., and Skelton, N.J. 1996. Protein NMR spectroscopy, principles and practice. Academic Press, San Diego, CA.
4. Cheriyath, V. and Roy, A.L. 2001. Structure-function analysis of TFII-I. Roles of the N-terminal end, basic resion, and I-repeat. J. Biochem. 276: 8377-8383.
5. Cheriyath, V., Desgranges, Z.P., and Roy, A.L. 2002. c-Src-dependent transcriptional activation of TFII-I. J. Biol. Chem. 277: 22798-22805.
6. Cornilescu, G., Delaglio, F., and Bax, A. 1999. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 13: 289-302.
7. Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J., and Bax, A. 1995. Nmrpipe: A multidimensional spectral processing system based on Unix Pipes. J. Biomol. NMR 6: 277-293.
8. Ferre-D'Amare, A.R., Prendergast, G.C., Ziff, E.B., and Burley, S.K. 1993. Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain. Nature 363: 38-45.
9. Grueneberg, D.A., Henry, R.W., Brauer, A., Novina, C.D., Cheriyath, V., Roy, A.L., and Gilman, M. 1997. A multifunctional DNA-binding protein that promotes the formation of serum response factor/homeodomain complexes: Identity to TFII-I. Genes & Dev. 11: 2482-2493.
10. Güntert, P. 2003. Automated NMR protein structure calculation. Prog. NMR Spectrosc. 43: 105-125.
11. Holm, L. and Sander, C. 1993. Protein structure comparison by alignment of distance matrices. J. Mol. Biol. 233: 123-138.
12. Johnson, B.A. and Blevins, R.A. 1994. NMRView: A computer program for the visualization and analysis of NMR data. J. Biomol. NMR 4: 603-614.
13. Kawai, J., Shinagawa, A., Shibata, K., Yoshino, M., Itoh, M., Ishii, Y., Arakawa, T., Hara, A., Fukunishi, Y., Konno, H., et al. 2001. Functional annotation of a full-length mouse cDNA collection. Nature 409: 685-690.
14. Kigawa, T., Yabuki, T., Yoshida, Y., Tsutsui, M., Ito, Y., Shibata, T., and Yokoyama, S. 1999. Cell-free production and stable-isotope labeling of milligram quantities of proteins. FEBS Lett. 442: 15-19.
15. Kim, D.-W. and Cochran, B.H. 2000. Extracellular signal-regulated kinase binds to TFII-I and regulates its activation of the c-fos promoter. Mol. Cell. Biol. 20: 1140-1148.
16. Kim, D.-W. and Cochran, B.H. 2001. JAK2 activates TFII-I and regulates its interaction with extracellular signal-regulated kinase. Mol. Cell. Biol. 21: 3387-3397.
17. Koradi, R., Billeter, M., and Wuthrich, K. 1996. MOLMOL: A program for display and analysis of macromolecular structures. J. Mol. Graph. 14: 51-55.
18. Korenberg, J.R., Chen, X.N., Hirota, H., Lai, Z., Bellugi, U., Burian, D., Roe, B., and Matsuoka, R. 2000. VI. Genome structure and cognitive map of Williams syndrome. J. Cogn. Neurosci. 12: 89-107.
19. Laskowski, R.A., Rullmannn, J.A., MacArthur, M.W., Kaptein, R., and Thornton, J.M. 1993. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8: 477-486.
20. Mervis, C.B. 2003. Williams syndrome: 15 years of psychological research. Dev. Neuropsychol. 23: 1-12.
21. Ogura, Y., Azuma, M., Tsuboi, Y., Kabe, Y., Yamaguchi, Y., Wada, T., Watanabe, H., and Handa, H. 2005. TFII -I down-regulates a subset of estrogen-responsive genes through its interaction with an initiator element and estrogen receptor α. Genes Cells 11: 373-381.
22. Perez Jurado, L.A. 2003. Williams-Beuren syndrome: A model of recurrent genomic mutation. Horm. Res. 59: 106-113.
23. Roy, A.L. 2001. Biochemistry and biology of the inducible multifunctional transcription factor TFII-I. Gene 274: 1-13.
24. Roy, A.L., Du, H., Gregor, P.D., Novina, C.D., Martinez, E., and Roeder, R.G. 1997. Cloning of an Inr- and E-box-binding protein, TFII-I, that interacts physically and functionally with USF1. EMBO J. 16: 7091-7104.
25. Tassabehji, M. 2003. Williams-Beuren syndrome: A challenge for genotype-phenotype correlations. Hum. Mol. Genet. 12: R229-R237.
26. Thompson, J.D., Gibson, T.J., Plewniak, F., Jeanmougin, F., and Higgins, D.G. 1997. The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25: 4876-4882.
27. Yang, W. and Desiderio, S. 1997. BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement. Proc. Natl. Acad. Sci. 94: 604-609.